Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Countries

 

Lusiadas Saude for sale

HBI hears Lusiadas Saude, Portugal’s third-largest hospital group by revenue, is for sale. Meanwhile, imaging and labs may be affected by the surprise re-election of the leftist Socialist government. HBI speaks with a healthcare consultant in Portugal to find out more. 
February 10, 2022

The difficulty in making money from primary care in France

In contrast to other European countries such as the UK, Ireland and Sweden, France is not currently seeing consolidation of its primary care sector by major corporate entities. HBI speaks to Thomas Breuvart, associate and investor in healthcare at French evergreen investment firm Creadev, to find out why.
February 10, 2022

Interview: Andrew Knight, CEO, Care UK

With all the recent well publicised criticisms of care homes in France, the spotlight is very much on quality in the sector. Who better to talk to then than Andrew Knight, CEO of Care UK, which according to UK healthcare watchdog the Care Quality Commission, has 16% outstanding sites against a market average of 4%, and 89% of its sites are rated good or outstanding.
February 10, 2022

New Dutch cabinet looks to shift elderly out of care homes

Elections in the Netherlands last year saw Mark Rutte, the Liberal prime minister, return for a fourth term, and belatedly we now have a new cabinet. Could we see a new direction for healthcare following this new mandate?
February 9, 2022

Pictet launches Private Equity focused on health investment

Swiss multinational private bank and financial services company Pictet is launching a private equity fund for the healthcare sector. The company plans to invest in five key segments: therapeutics, diagnostics, digital health, medical technology, and health care and services providers.
February 8, 2022

Stanley Capital acquires DSS

Stanley Capital, the London-based private equity fund, is to buy Drug Safety and Pharmacovigilance Services Solutions ("DSS") from Clario, a global clinical trials player. "DDS" specializes in pharmacovigilance - the assessment and monitoring of interactions between drugs and their effects on the human body. HBI talks to Simon Cottle, the founding partner at Stanley Capital.
February 3, 2022

For-profit fertility sector growing strongly

The European fertility sector has been growing strongly, at around 5% per annum, and in some places even more strongly than this. The strong growth in the sector is driven by increasing demand, which is driven by a decline in fertility and the increasing social acceptability of IVF treatment. The data in this infographic is […]
February 3, 2022

Sanitas doubles rehabilitation centres in Spain

Spanish hospital group Sanitas Hospitales (a subsidiary of Bupa-owned insurance firm Sanitas) is launching seven new rehabilitation centres in Spain. The new Advanced Rehabilitation Centers will be opened mainly in Madrid. Alongside eight remaining centres located in Madrid, Valencia and Zaragoza, Sanitas will own 15 monographic rehabilitation centres in Spain. Sanitas CEO Inaki Peralta announced […]
February 3, 2022

New Czech government set to liberalise health care market

The new centre-right Czech government will try to liberalise the healthcare market, could introduce supplementary insurance and may even reintroduce hugely unpopular co-pays. HBI talks with Dr Oldrich Subtr, the founder of Program Health Plus, a private polyclinic based in Prague.
February 3, 2022
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us